
In part one of the three-part series on writing a strong commercialization plan, NCI SBIR Program Director William Bozza invites NCI SBIR-funded biotech innovators, Sid Selvaraj, co-founder and CEO of Arima Genomics, and Manijeh Goldberg, president, founder, and CEO of Privo Technologies, to share advice for aspiring phase II SBIR/STTR applicants:
https://sbir.cancer.gov/small-business-funding/grants/bridge-award
SBIR DEVELOPMENT CENTER
SBIR Innovation Lab Podcast: https://sbir.cancer.gov/about/innovation-lab-podcast
SBIR Development Center: https://sbir.cancer.gov/
LEARN MORE FROM THE NATIONAL CANCER INSTITUTE
Online: https://www.cancer.gov
By Phone: 1-800-4-CANCER (1-800-422-6237)
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
Weitere Episoden von „SBIR Innovation Lab“



Verpasse keine Episode von “SBIR Innovation Lab” und abonniere ihn in der kostenlosen GetPodcast App.








